Personalized Cancer Vaccine Shows Long-Term Survival for Patients with High-Risk Melanoma
August 06, 2020

Data released from a phase 2b clinical trial showed statistically significant long-term survival for patients with stage III or IV melanoma at high-risk of recurrence.

FDA Approves Atezolizumab Plus Cobimetinib and Vemurafenib for Advanced Melanoma
July 30, 2020

The FDA approved atezolizumab plus cobimetinib and vemurafenib for the treatment of patients with BRAF V600 mutation-positive advanced melanoma.

Lower Risk of Melanoma Diagnosis and Increased Mortality Following Partner Bereavement
March 05, 2020

These findings highlight the need to raise public awareness of the importance of self-skin examination, and to encourage clinicians to have a lower threshold for undertaking skin examinations in bereaved individuals, according to the researchers.